8-K: NextNRG closes third tranche of convertibles

Sentiment:

Financing Update


NextNRG completed a third closing of senior secured convertible notes with 18% OID, raising $2.5 million in gross proceeds and issuing additional warrants, with underlying shares registered on its S-3.

Capital raiseThird Closing: $2,950,000 senior secured convertible notes issued with 18% OID (gross proceeds $2,500,000).Third Closing: 750,000 warrants at $5.00 exercise price; $295,000 due diligence notes and 75,000 due diligence warrants.Conversion price for Third Closing notes and due diligence notes set at $1.688 per share.Aggregate to date: $7,500,000 gross proceeds across three closings; $8,850,000 notes principal and $885,000 due diligence notes; 2,250,000 warrants and 225,000 due diligence warrants issued.Underlying shares for Third Closing and any additional closings registered on Form S-3 (File No. 333-268960) via Prospectus Supplement (amended November 18, 2025).Legal opinion (Exhibit 5.1) covers up to 5,494,770 shares issuable under the Third Closing and potential additional closings.

Summary

  • Completed a Third Closing on November 12, 2025 under a September 8, 2025 securities purchase agreement, issuing $2,950,000 of senior secured convertible notes with an 18% original issue discount (gross proceeds: $2,500,000).
  • Issued 750,000 warrants (exercise price: $5.00) and $295,000 of due diligence notes plus 75,000 due diligence warrants in the Third Closing.
  • Set the conversion price for Third Closing notes and due diligence notes at $1.688 per share.
  • Prior tranches: Initial Closing on September 8, 2025 and a Second Closing across October 3 and October 22, 2025, each mirroring the Third Closing structure and each providing $2,500,000 in gross proceeds.
  • Aggregate to date across three closings: $8,850,000 in note principal issued, $7,500,000 gross proceeds received, $885,000 due diligence notes, 2,250,000 warrants and 225,000 due diligence warrants issued.
  • Underlying shares for the Third Closing registered via shelf registration statement on Form S-3 (File No. 333-268960) and Prospectus Supplement amended on November 18, 2025.
  • Legal opinion (Exhibit 5.1) confirms up to 5,494,770 shares are duly authorized and, when issued under the instruments, will be validly issued, fully paid and nonassessable.
  • Structure allows for potential additional closings under the Purchase Agreement, with related shares also covered by the amended Prospectus Supplement.

Sentiment

Score: 5

Explanation: Neutral overall: liquidity strengthened by expected funding, offset by high-cost, secured, and potentially dilutive financing terms.

Positives

  • Secured $2,500,000 in new gross proceeds at the Third Closing, enhancing near-term liquidity.
  • All underlying securities for the Third Closing and any additional closings registered on the existing S-3 with a Prospectus Supplement amendment filed November 18, 2025.
  • Clear pricing terms: $1.688 conversion price for Third Closing notes and $5.00 warrant exercise price.
  • Legal opinion filed affirming the validity of up to 5,494,770 issuable shares tied to the Third Closing and potential additional closings.
  • Transaction terms remained consistent across closings (aside from the Third Closing conversion price), supporting predictability of funding tranches.

Negatives

  • Financing features an 18% original issue discount, indicating a higher cost of capital.
  • Convertible notes and attached warrants create potential share dilution upon conversion and exercise.
  • Notes are senior secured, adding a first-priority claim on assets ahead of equity holders.
  • Potential for additional closings under the Purchase Agreement could introduce further dilution.

Future Outlook

The Purchase Agreement permits additional closings beyond the Third Closing, with underlying shares already covered by the amended Prospectus Supplement; no operating or financial guidance is provided.

Industry Context

Small-cap issuers on the Nasdaq Capital Market commonly use secured convertible notes with warrant coverage when accessing capital markets is constrained; the structure provides liquidity but typically comes with higher cost and dilution risk versus larger-cap convertible issuers that often secure lower-cost terms without original issue discounts.

Comparison to Industry Standards

  • Cost of capital: An 18% original issue discount is higher than terms seen in many larger-cap convertible offerings (which often have little to no OID), indicating a comparatively expensive financing typical of smaller-cap issuers.
  • Structure: Senior secured convertibles with accompanying warrants reflect a more dilutive, investor-protective structure than unsecured converts often issued by larger peers in clean tech and EV infrastructure.
  • Warrant coverage: For the Third Closing, 750,000 warrants alongside approximately 1,747,631 conversion shares equates to roughly 43% warrant coverage, which is elevated compared to many investment-grade convertible financings that carry no warrants.

Stakeholder Impact

  • Shareholders: Potential dilution from conversion of notes and exercise of warrants and due diligence warrants.
  • Creditors: Introduction of senior secured debt increases claims ahead of equity, potentially affecting capital structure priority.
  • Company liquidity: $2,500,000 additional cash received at the Third Closing improves near-term funding flexibility.
  • Market overhang: Warrant and convertible overhang may weigh on stock performance until absorbed or exercised.

Next Steps

  • Potential additional closings under the September 8, 2025 Purchase Agreement.
  • Issuance of shares upon conversion of notes and due diligence notes, and upon exercise of warrants, as applicable.
  • Ongoing compliance under the registered shelf (Form S-3) and Prospectus Supplement framework.

Key Dates

DateDescription
2022-12-22Shelf registration statement on Form S-3 (File No. 333-268960) filed.
2023-01-03Shelf registration statement on Form S-3 declared effective.
2025-09-08Securities Purchase Agreement executed and Initial Closing completed (issued $2,950,000 notes, $295,000 due diligence notes, 750,000 warrants, 75,000 due diligence warrants; gross proceeds $2,500,000).
2025-09-09Prospectus Supplement to the S-3 filed.
2025-10-03Second Closing (part 1) consummated; aggregate with October 22 provided $2,500,000 gross proceeds.
2025-10-22Second Closing (part 2) consummated; aggregate principal issued $2,950,000 notes and $295,000 due diligence notes; warrants as in Initial Closing.
2025-11-12Third Closing completed (issued $2,950,000 notes at $1.688 conversion price; $295,000 due diligence notes at $1.688; 750,000 warrants at $5.00; 75,000 due diligence warrants; gross proceeds $2,500,000).
2025-11-18Prospectus Supplement No. 1 filed; legal opinion dated and 8-K signed by the CEO.

Recommendation

hold

The company executed a planned financing tranche, improving liquidity, but the structure is high-cost and dilutive (18% OID, senior secured convertibles with warrant coverage). Without incremental operating updates or guidance, the risk-reward remains balanced; maintain a neutral stance pending visibility on use of proceeds and operating performance.

Keywords

convertible notes, warrants, original issue discount, shelf registration, Form S-3, Prospectus Supplement, Rule 506(b), Section 4(a)(2), Nasdaq Capital Market, NextNRG, NXXT, capital raise, secured debt, dilution, legal opinion

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.